These authors showed that EV-associated ILK is sufficient to promote EMT and metabolic reprogramming in recipient mammary epithelial cells, thus highlighting the key role of EV cargo in breast cancer progression [13]. The gene discussed is ILK; the disease is breast carcinoma.